FYR Diagnostics Announces New Large-Scale COVID-19 Test Processing Capability for Montana

MISSOULA, Mont., Oct. 7, 2020 /PRNewswire/ --FYR Diagnostics, a Missoula- based biotechnology company announced that it will immediately begin processing COVID-19 tests to help increase Montana's overall testing capacity. FYR will use a test that was developed by the Centers for Disease Control and is authorized by the FDA under an Emergency Use Authorization (EUA). The company will process tests in its CLIA-certified laboratory using a highly accurate process called reverse transcription polymerase chain reaction (RT-PCR). "RT-PCR tests are the gold standard for the detection of viral pathogens," said Chris Booth, PhD, CEO and Director of Research & Development. "Before the eventualA arrival of a vaccine, Montana needs to expand its testing infrastructure to monitor the spread of the COVID-19 virus and prepare for the deployment of the vaccine."FYR will provide preassembled sample collection kits compatible with RT-PCR testing to Montana universities, hospitals, businesses, and healthcare providers who will perform the sample collection. The kits include swabs and transport media that will inactivate viral samples and preserve them at room temperature for safe transport. The samples will then be returned to FYR for rapid processing in Missoula. FYR Diagnostics is a company focused on the development of nextA generation tests for the early detection of human andA agricultural diseases,A but its team of scientists felt compelled to turn its expertise towards helping Montana during this pandemic."Through ourA efforts we hope to do our part and reduce the burden of COVID-19 in our community," said Vikas Ghai, PhD, Senior Research Scientist, FYR Diagnostics. "It is exciting to be a part of a team that can positively impact the health and safety of the public."
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2021    »